Close Menu

NEW YORK (GenomeWeb) – Israeli molecular diagnostics firm Pronto Diagnostics recently said that it has combined its suite of genetic tests with FDNA's Face2Gene phenotyping applications.

Pronto offers both next-generation sequencing-based gene panels and exome testing as well as single-gene molecular tests.

FDNA's Face2Gene technology uses facial analysis, deep learning, and artificial intelligence to improve molecular diagnostics. It enables clinicians to integrate phenotypic data into genetic testing pipelines in order to improve the chances of making a diagnosis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.